Clinical Trial Update: Anticoagulation in AF Ablation and Effects on Neurocognitive Function [Phase 4]

View source ↗

Summary

This Phase 4 trial investigating anticoagulation in atrial fibrillation patients undergoing ablation and its effects on neurocognitive function has been withdra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Cerebral Embolism
• Stroke

Snippet

Sponsor: University of California, San Francisco | Conditions: Atrial Fibrillation, Cerebrothromboembolus | Phase 4 | Status: WITHDRAWN